DUNNE MICHAEL W. (Chief Scientific Officer) purchased 2.6% of their position (6K shares) of ITERUM THERAPEUTICS PLC on the open market
Open‑market purchase worth $2.2K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 11/20/2025ACC: 0001193125-25-288848
Officer· Chief Scientific Officer
Since Aug 2018
+6K
Net shares
Net buyer
$2.2K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
6K acquired
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
+6K
Price / share
$0.37
Trade value
$2.19K
% of position
2.6%
11/18/2025
235K→241K
Total
Net shares
+6K
Net value
$2.19K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 11/18/2025 | P · Purchase | +6K | $0.37 | $2.19K | 2.6% | 235K | 241K |
| Total | +6K | $2.19K | ||||||
Derivative Transactions0
No derivative transactions reported